Canadian guidelines for the management of acute exacerbations of chronic bronchitis

Meyer S. Balter; Jacques La Forge; Donald E. Low; Lionel Mandell; Ronald F. Grossman; Antonio Anzueto; Abraham Born; Jacques Bouchard; Nigel J.D. Duguid; Godfrey Harding; Marcel Julien; Noel Lampron; Robert D. Levy; James A. McSherry; Karl A. Weiss

doi:10.1155/2003/486285

Canadian guidelines for the management of acute exacerbations of chronic bronchitis

Meyer S. Balter, Jacques La Forge, Donald E. Low, Lionel Mandell, Ronald F. Grossman, Antonio Anzueto, Abraham Born, Jacques Bouchard, Nigel J.D. Duguid, Godfrey Harding, Marcel Julien, Noel Lampron, Robert D. Levy, James A. McSherry, Karl A. Weiss

Department of Medicine

Research output: Contribution to journal › Review article › peer-review

136 Scopus citations

Abstract

Acute exacerbations of chronic bronchitis (AECB) account for over 1.5 million physician visits annually in Canada and are a cause of significant morbidity and mortality. This document represents a joint effort between respirologists, microbiologists, infectious disease specialists and family physicians to update the Canadian AECB guidelines published in 1994. Treatment recommendations are graded on the strength of evidence in the published literature where possible. The role for oral corticosteroid therapy in preventing treatment failures, speeding up recovery and delaying the time to next exacerbation is discussed. Risk factors for treatment failure were used to stratify patients into risk groups to help guide antibiotic treatment recommendations. The importance of emerging antimicrobial resistance to current antibiotics is reviewed and strategies to prevent future AECB episodes are suggested.

Original language	English (US)
Pages (from-to)	3B-32B
Journal	Canadian Respiratory Journal
Volume	10
Issue number	SUPPL. B
DOIs	https://doi.org/10.1155/2003/486285
State	Published - 2003

Keywords

Antibiotics
Chronic bronchitis
Exacerbatiosn
Risk stratification

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1155/2003/486285

Cite this

Balter, M. S., La Forge, J., Low, D. E., Mandell, L., Grossman, R. F., Anzueto, A., Born, A., Bouchard, J., Duguid, N. J. D., Harding, G., Julien, M., Lampron, N., Levy, R. D., McSherry, J. A., & Weiss, K. A. (2003). Canadian guidelines for the management of acute exacerbations of chronic bronchitis. Canadian Respiratory Journal, 10(SUPPL. B), 3B-32B. https://doi.org/10.1155/2003/486285

Balter, MS, La Forge, J, Low, DE, Mandell, L, Grossman, RF, Anzueto, A, Born, A, Bouchard, J, Duguid, NJD, Harding, G, Julien, M, Lampron, N, Levy, RD, McSherry, JA & Weiss, KA 2003, 'Canadian guidelines for the management of acute exacerbations of chronic bronchitis', Canadian Respiratory Journal, vol. 10, no. SUPPL. B, pp. 3B-32B. https://doi.org/10.1155/2003/486285

@article{791bfdfa4757408e97939771ae7e48b7,

title = "Canadian guidelines for the management of acute exacerbations of chronic bronchitis",

abstract = "Acute exacerbations of chronic bronchitis (AECB) account for over 1.5 million physician visits annually in Canada and are a cause of significant morbidity and mortality. This document represents a joint effort between respirologists, microbiologists, infectious disease specialists and family physicians to update the Canadian AECB guidelines published in 1994. Treatment recommendations are graded on the strength of evidence in the published literature where possible. The role for oral corticosteroid therapy in preventing treatment failures, speeding up recovery and delaying the time to next exacerbation is discussed. Risk factors for treatment failure were used to stratify patients into risk groups to help guide antibiotic treatment recommendations. The importance of emerging antimicrobial resistance to current antibiotics is reviewed and strategies to prevent future AECB episodes are suggested.",

keywords = "Antibiotics, Chronic bronchitis, Exacerbatiosn, Risk stratification",

author = "Balter, {Meyer S.} and {La Forge}, Jacques and Low, {Donald E.} and Lionel Mandell and Grossman, {Ronald F.} and Antonio Anzueto and Abraham Born and Jacques Bouchard and Duguid, {Nigel J.D.} and Godfrey Harding and Marcel Julien and Noel Lampron and Levy, {Robert D.} and McSherry, {James A.} and Weiss, {Karl A.}",

year = "2003",

doi = "10.1155/2003/486285",

language = "English (US)",

volume = "10",

pages = "3B--32B",

journal = "Canadian Respiratory Journal",

issn = "1198-2241",

publisher = "Pulsus Group Inc.",

number = "SUPPL. B",

}

TY - JOUR

T1 - Canadian guidelines for the management of acute exacerbations of chronic bronchitis

AU - Balter, Meyer S.

AU - La Forge, Jacques

AU - Low, Donald E.

AU - Mandell, Lionel

AU - Grossman, Ronald F.

AU - Anzueto, Antonio

AU - Born, Abraham

AU - Bouchard, Jacques

AU - Duguid, Nigel J.D.

AU - Harding, Godfrey

AU - Julien, Marcel

AU - Lampron, Noel

AU - Levy, Robert D.

AU - McSherry, James A.

AU - Weiss, Karl A.

PY - 2003

Y1 - 2003

N2 - Acute exacerbations of chronic bronchitis (AECB) account for over 1.5 million physician visits annually in Canada and are a cause of significant morbidity and mortality. This document represents a joint effort between respirologists, microbiologists, infectious disease specialists and family physicians to update the Canadian AECB guidelines published in 1994. Treatment recommendations are graded on the strength of evidence in the published literature where possible. The role for oral corticosteroid therapy in preventing treatment failures, speeding up recovery and delaying the time to next exacerbation is discussed. Risk factors for treatment failure were used to stratify patients into risk groups to help guide antibiotic treatment recommendations. The importance of emerging antimicrobial resistance to current antibiotics is reviewed and strategies to prevent future AECB episodes are suggested.

AB - Acute exacerbations of chronic bronchitis (AECB) account for over 1.5 million physician visits annually in Canada and are a cause of significant morbidity and mortality. This document represents a joint effort between respirologists, microbiologists, infectious disease specialists and family physicians to update the Canadian AECB guidelines published in 1994. Treatment recommendations are graded on the strength of evidence in the published literature where possible. The role for oral corticosteroid therapy in preventing treatment failures, speeding up recovery and delaying the time to next exacerbation is discussed. Risk factors for treatment failure were used to stratify patients into risk groups to help guide antibiotic treatment recommendations. The importance of emerging antimicrobial resistance to current antibiotics is reviewed and strategies to prevent future AECB episodes are suggested.

KW - Antibiotics

KW - Chronic bronchitis

KW - Exacerbatiosn

KW - Risk stratification

UR - http://www.scopus.com/inward/record.url?scp=0141670266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141670266&partnerID=8YFLogxK

U2 - 10.1155/2003/486285

DO - 10.1155/2003/486285

M3 - Review article

C2 - 12944998

AN - SCOPUS:0141670266

SN - 1198-2241

VL - 10

SP - 3B-32B

JO - Canadian Respiratory Journal

JF - Canadian Respiratory Journal

IS - SUPPL. B

ER -

Canadian guidelines for the management of acute exacerbations of chronic bronchitis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this